EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 619 (2025) E3S Web Conf., 619 (2025) 04013 References
Open Access
Issue
E3S Web Conf.
Volume 619, 2025
3rd International Conference on Sustainable Green Energy Technologies (ICSGET 2025)
Article Number 04013
Number of page(s) 11
Section Materials for a Sustainable Future
DOI https://doi.org/10.1051/e3sconf/202561904013
Published online 12 March 2025
  1. Bastaki S. “Diabetes mellitus and its treatment.” International Journal of Diabetes and Metabolism 2005,13 (3), 111–134. [CrossRef] [Google Scholar]
  2. Abdulfatai BO, Olusegun AO, and Lateefat BO, “Type 2 Diabetes Mellitus: A Review of Current Trends.” Oman Medical Journal, 2012,27(4); 269-273. [CrossRef] [Google Scholar]
  3. Balamurugan, K., Mishra, K., & Suresh, R. Sitagliptin: a literature review on analytical and bio-analytical methods. Pharma Innov J, 2018 7, 357-361. [Google Scholar]
  4. Behera, S. R., Mohapatra, A., Sahu, P. R., Mishra, T., Sankar, C. G., & Mishra, K. Teneligliptin: A Literature Review on Analytical and Bio-Analytical Methods. ejpmr, 2021,8(11), 223-228 [Google Scholar]
  5. Mariana Teixeira da Trindade, Ana Carolina Kogawa & Hérida Regina Nunes Salgado (2018) Metformin: A Review of Characteristics, Properties, Analytical Methods and Impact in the Green Chemistry, Critical Reviews in Analytical Chemistry, 48:1, 66-72 [CrossRef] [PubMed] [Google Scholar]
  6. Polyakova, E.B., Sabirzyanov, D.R., Prozorova, N.A. et al. Physicochemical Properties and Methods of Analysis of Vildagliptin (Review). Pharm Chem J 2022, 56, 110–117. https://doi.org/10.1007/s11094-022-02606-1 [CrossRef] [PubMed] [Google Scholar]
  7. PubChem - Database of Chemical Compounds and Mixtures [Electronic resource], https: // pubchemncbinlm nihgov / compound / 6918537#section = Chemical-and- Physical- Properties. [Google Scholar]
  8. Herman G, Bergman A, Liu F, Stevens C, Wang A, Zeng W et al. Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects. J Clin Pharmacol. 2006; 46(8):876-886. [CrossRef] [PubMed] [Google Scholar]
  9. Yoshida T, Akahoshi F, Sakashita H, et al. Discovery and preclinical profile of Teneligliptin(3- [(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin- yl]pyrrolidin-2- ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bio org Med Chem, 2012; 20(19): 5705–5719. [CrossRef] [Google Scholar]
  10. National Center for Biotechnology Informatio. PubChem Compound Summary for CID 4091, Metformin. Retrieved July 28, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Metformin. [Google Scholar]
  11. National Center for Biotechnology Information. PubChem Compound Summary for CID 4369359, Sitagliptin. Retrieved July 28, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Sitagliptin. [Google Scholar]
  12. National Center for Biotechnology Information. PubChem Compound Summary for CID 11949652, Teneligliptin. Retrieved July 28, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Teneligliptin. [Google Scholar]
  13. National Center for Biotechnology Information. PubChem Compound Summary for CID 6918537, Vildagliptin. Retrieved July 28, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Vildagliptin. [Google Scholar]
  14. Judeh, A. A., Sarief, A., Umar, Y., Ashwaq, O., & Haque, S. M. Development, computational studies and validation of spectrophotometric method of metformin hydrochloride in pharmaceutical formulations. Journal of the Chilean Chemical Society, 2020, 65(3), 4895-4899. [CrossRef] [Google Scholar]
  15. Dayyih, W. A., Hamad, M., Mallah, E., Dayyih, A. A., Awad, R., Zakaria, Z., & Arafat, T. .METHOD Development and Validation of Vildagliptin and Metformin HCl in Pharmaceutical Dosage form by Reversed Phase-High Performance Liquid Chromatography (RP-HPLC). International Journal of Pharmaceutical Sciences and Research, 2018,9(7), 2965-2972. [Google Scholar]
  16. M. Anusha and N Ponnu Swamy, Bioanalytical Method Development and Validation of Teneligliptin UsingRP-HPLC in rabbit plasma, Indo Am. J. P. Sci, 2017; 4(08) [Google Scholar]
  17. Indian Pharmacopeia, 9 Edn; Government of India, Ministry of Health & Family Welfare, Indian Pharmacopeia Commission, Ghaziabad,2022, Vol-II, III, pp 2874- 2875, 3587-3588 [Google Scholar]
  18. British Pharmacopoeia, 11th Edn; Medicines and Healthcare products regulatory Agency, British Pharmacopeial commission, London, 2022, Vol-III, pp 967-970,1336- 1337. [Google Scholar]
  19. US Pharmacopeia 46, NF 41, The United State Pharmacopeia Convention Inc, Rockville,2022, pp 6034-6036. [Google Scholar]
  20. European Pharmacopoeia, 11th Edition, European Pharmacopeia Commission, pp3213,3796 [Google Scholar]
  21. Verterqvist, O.; Nabbie, F.; Swanson, B. Determination of Metformin in Plasma by High-Performance Liquid Chromatography After Ultrafiltration. J. Chromatogr. B: Biomed. Sci. Appl. 1998, 716, 299–304. [CrossRef] [Google Scholar]
  22. Amini, H.; Ahmadiani, A.; Gazerani, P. Determination of Metformin in Human Plasma by High-Performance Liquid Chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2005, 82, 139–322. [Google Scholar]
  23. Chen, X.; Gu, Q.; Qiu, F.; Zhong, D. Rapid Determination of Metformin in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Method. J. Chromatogr B Anal. Technol. Biomed. Life Sci. 2004, 802, 2, 377–381. [CrossRef] [Google Scholar]
  24. JP. Japanese Pharmacopoeia, 16th ed. Tokyo Society of Japanese Pharmacopoeia: Tokyo, 2011. [Google Scholar]
  25. Radwan, M. A.; Al Taweel, E. S.; Abdulrahman, M.; Aloudah, N. M.; Al Babtain, M. A.; Al-Amri, H. S. Monitoring Metformin in Cardiac Patients Exposed to Contrast Media Using Ultra-High-Performance Liquid Chromatography Tandem Mass- Spectrometry. Therapeutic Drug Monit. 2011, 33, 6, 742–749, 2011. [Google Scholar]
  26. USP 39. The United States Pharmacopeia, 39th ed.; United States Convention: Rockville, 2016. [Google Scholar]
  27. Karim, R., Poly, N., & Banoo, R. (2012). Development and validation of UV spectroscopic method for the determination of metformin hydrochloride in tablet dosage form. International journal of pharmaceutical sciences and research, 2012, 3(9), 3170. [Google Scholar]
  28. Reddy, N. P., & Chevela, N. T. (2015). RP-HPLC Method development and validation for the Simultaneous Estimation of Metformin and Canagliflozin in Tablet Dosage Form. International Journal of Pharma Sciences, 2015, 5(4), 1155-1159. [Google Scholar]
  29. Rao, S. V., Gollu, S. R., Krishna, A. G., Ameer, S. K., & Sekar, K. C. (2011). Estimation of Metformin Hydrochloride and Pioglitazone Hydrochloride in their Bulk and Formulation Dosage fForms by using RPHPLC Method. Oriental Journal of Chemistry, 2011, 27(3), 1221. [Google Scholar]
  30. Alleswararao CSNM, Suryanarayana MV and Mukkanti K. “Simultaneous Determination of Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride in Tablets by a Validated UPLC Method” Sci Pharm. 2012, 80, 139–152 [CrossRef] [Google Scholar]
  31. Adsul S, Bidkar JS ,Harer S, et al. “RP- HPLC Method Development and Validation for Simultaneous Estimation for Metformin and Sitagliptin in Bulk and Tablet Formulation.” International Journal of ChemTech Research, 2018,11(11), 428-435 [CrossRef] [Google Scholar]
  32. Nyola N and Jeyabalan GS. “Method Development of Simultaneous Estimation of Sitagliptin And Metformin Hydrochloride in Pure and Tablet Dosage Form By UV-Vis Spectroscopy.” World Journal Of Pharmacy And Pharmaceutical Sciences. 2012, 1(4), 1392-1401. [Google Scholar]
  33. Reddy S, Ahmed I, Ahmad I, et al. “Development and Validation of a Method for Simultaneous Estimation of Metformin and Sitagliptin in Human Plasma by LC-MS- MS and Its Application in a Bioequivalence Study” Journal of Chromatographic Science. 2015, 53, 1549–1556. [CrossRef] [PubMed] [Google Scholar]
  34. Raja T and Rao AL.” Validated Hptlc Method For Simultaneous Estimation of Metformin Hydrochloride and Sitagliptin Phosphate in Bulk Drug and Formulation” Rasayan J. Chem., 2012, 5(3), 407-413 [Google Scholar]
  35. Peraman R, Gowra CS, Reddy YP, et al. “Stability-Indicating RP-HPLC Method for Simultaneous Determination of Metformin Hydrochloride and Sitagliptin Phosphate in Dosage Forms.” Chromatographia, 2013 76, 1153–1162 [Google Scholar]
  36. Sen, A. K., Hinsu, D. N., Sen, D. B., Zanwar, A. S., Maheshwari, R. A., & Chandrakar, V. R. Analytical method development and validation for simultaneous estimation of Teneligliptin hydrobromide hydrate and Metformin hydrochloride from it’s pharmaceutical dosage form by three different UV spectrophotometric methods. Journal of Applied Pharmaceutical Science, 2016, 6(9), 157-165. [CrossRef] [Google Scholar]
  37. Chaitanya SM “Simultaneous Determination of Metformin and Teneligliptin by Liquid Chromatography in tablets.” Asian Journal of Pharmaceutics, 2018, 12 (02) [Google Scholar]
  38. Patel M, Patel D, Shah U, et al.” Simultaneous quantification of teneligliptin hydrobromide and metformin hydrochloride: an improved HPTLC method with the implementation of Plackett-Burman design” J. Chem. Metrol. 2021, 15(1), 65-75 [CrossRef] [Google Scholar]
  39. Patel V, Pandya C, Patel Z, et al. “Isocratic RP-UHPLC method development and validation of stability-indicating for simultaneous determination of teneligliptin and metformin in fixed-dose combination.” Current Chemistry Letters, 2021, 10(4), 503-516. [CrossRef] [Google Scholar]
  40. Dayyih WA, Hamad M, Mallah E, et al.: “Method development and validation of vildagliptin and metformin HCl in pharmaceutical dosage form by Reverse Phase– High-Performance Liquid Chromatography (RP-HPLC)”. Int J Pharm Sci Res. 2018, 9(7), 2965-72. [Google Scholar]
  41. Patel V, Pandya C, Pandya A, et al. “Novel UHPLC DAD Method for Simultaneous determination of Vildagliptin and Metformin in Bulk and its Tablet formulation.” Research Journal of Pharmacy and Technology. 2021, 14(8), 4143-4150 [CrossRef] [Google Scholar]
  42. Gundala U et al., Simultaneous Estimation of Vildagliptin and Metformin in Bulk and Pharmaceutical Formulations by UV Spectrophotometr [Google Scholar]
  43. Ishaq MB, Dr. Prakash VK, Dr. Mohan GK. “RP-HPLC Method for Simultaneous Estimation of Metformin and Vildagliptin in Bulk and its Tablet Formulation.” JGTPS, 2012, 3(3), 747-754 [Google Scholar]
  44. Kumar, K. Dileep, N. Mukesh Reddy, J. Sai Priyanka, and K. Murugaperumal. “Design and Analyzing of DC Transformer Efficiency Enhancement for Microgrid Applications.” In 2023 4th International Conference for Emerging Technology (INCET), pp. 1-8. IEEE, 2023. [Google Scholar]
  45. El-Bagary, RI, Elkady, EF and Ayoub, BM. “Development and validation of a reversed-phase liquid chromatographic method for the determination of three Gliptins and Metformin in the presence of Metformin impurity (1-cyanoguanidine).” European Journal of Chemistry, 2013, 4(4), 444-449. [CrossRef] [Google Scholar]
  46. El-Kimary, E. I., Hamdy, D. A., Mourad, S. S., & Barary, M. A. HPTLC determination of three gliptins in binary mixtures with metformin. Journal of Chromatographic science, 2016 54(1), 79-87. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.